PRESS RELEASE published on 05/16/2025 at 08:30, 10 months 11 days ago Oxurion announces the signing of a binding agreement to acquire French biometrics specialist Axiodis CRO Oxurion NV to acquire 72% of Axiodis CRO shares for €468,000, valuing the company at €650,000. Deal expected to close by June 2025. Axiodis CRO specializes in clinical biometrics, offers integrated services for clinical trials, and aims for revenue growth Acquisition Revenue Growth Oxurion NV Axiodis CRO Clinical Biometrics
BRIEF published on 05/15/2025 at 18:05, 10 months 12 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Acquisition Actions Transparency Atlas Special Opportunities Oxurion
PRESS RELEASE published on 05/15/2025 at 18:00, 10 months 12 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion announces receipt of transparency notifications regarding share ownership by Atlas Special Opportunities II, LLC, crossing thresholds under and above 5% and 25% Share Ownership Thresholds Oxurion Atlas Special Opportunities II Transparency Notifications
BRIEF published on 05/12/2025 at 18:05, 10 months 15 days ago Oxurion Reports Shares Threshold Crossings by Atlas Special Opportunities Transparency Notification Atlas Special Opportunities Oxurion Shareholding Thresholds Retinal Disease Therapies
PRESS RELEASE published on 05/12/2025 at 18:00, 10 months 15 days ago Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC Oxurion NV received transparency notifications regarding changes in shareholding percentages from Atlas Special Opportunities II, LLC. The biopharmaceutical company is focused on developing ophthalmic therapies for retinal disease Biopharmaceutical Shareholding Changes Ophthalmic Therapies Oxurion NV Transparency Notifications
BRIEF published on 05/09/2025 at 18:05, 10 months 18 days ago Oxurion Increases Capital Following Convertible Bond Conversion Convertible Bonds Capital Increase Atlas Special Opportunities Vision Preservation Oxurion Shares
PRESS RELEASE published on 05/09/2025 at 18:00, 10 months 18 days ago Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC converts 4 convertible bonds in Oxurion, resulting in EUR 100,000 capital increase, supporting innovative therapeutics development for vision preservation in elderly. Oxurion shares update post-capital increase Capital Increase Oxurion Atlas Special Opportunities, LLC Innovative Therapeutics Vision Preservation
BRIEF published on 04/25/2025 at 18:35, 11 months 2 days ago Oxurion Stops 2024 Transaction and Continues Negotiations for New Acquisition Acquisition Negotiations CRO Oxurion Biometrics
PRESS RELEASE published on 04/25/2025 at 18:30, 11 months 2 days ago Oxurion announces that the transaction of July 2024 is stopped and confirms continuation of discussions regarding the acquisition project announced in March 2025 Oxurion NV halts acquisition of French CRO, pursues deal with biometrics CRO to expand capabilities in clinical data management. Progress updates to follow Acquisition CRO Oxurion NV Clinical Data Management Biometrics
BRIEF published on 04/11/2025 at 20:05, 11 months 16 days ago Oxurion Publishes its 2024 Annual Report and Convenes its General Meeting Forward-looking Statements Annual Report 2024 Ophthalmic Therapies Shareholders' Meetings Oxurion NV
Published on 03/28/2026 at 01:00, 5 hours 26 minutes ago Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 5 hours 31 minutes ago Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 5 hours 36 minutes ago "Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 7 hours 41 minutes ago Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 7 hours 56 minutes ago Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property
Published on 03/28/2026 at 01:42, 4 hours 43 minutes ago EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 8 hours 27 minutes ago Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 10 hours 17 minutes ago EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria
Published on 03/27/2026 at 19:30, 10 hours 55 minutes ago Turning Potential into Reality: Future 500 Ignites Scale-Up Momentum in Europe
Published on 03/27/2026 at 19:30, 10 hours 55 minutes ago FONDAZIONE MAIRE PRESENTED IN BERLIN THE "CLIMATE GOALS" STUDY IN THE FRAMEWORK OF MAIRE EUROPEAN STRATEGY LEVERAGING ON GERMANY
Published on 03/27/2026 at 18:52, 11 hours 34 minutes ago Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 11 hours 45 minutes ago 2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 12 hours 33 minutes ago Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 12 hours 41 minutes ago PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025